反応式
Br[CH2:2][C:3]([NH:5][C:6]1[CH:11]=[CH:10][C:9]([C:12]2([C:17]3[CH:22]=[CH:21][C:20]([Cl:23])=[CH:19][CH:18]=3)[O:16][CH2:15][CH2:14][O:13]2)=[CH:8][C:7]=1[CH:24]([C:26]1[CH:31]=[CH:30][CH:29]=[C:28]([Cl:32])[CH:27]=1)[OH:25])=[O:4].CC(O)(C)C.[K].Cl>COCCOC>[Cl:32][C:28]1[CH:27]=[C:26]([CH:24]2[C:7]3[CH:8]=[C:9]([C:12]4([C:17]5[CH:22]=[CH:21][C:20]([Cl:23])=[CH:19][CH:18]=5)[O:16][CH2:15][CH2:14][O:13]4)[CH:10]=[CH:11][C:6]=3[NH:5][C:3](=[O:4])[CH2:2][O:25]2)[CH:31]=[CH:30][CH:29]=1参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
A mixture of intermediate (10) (0.072 mol) in DME (300 ml) was cooled on an ice bath. 2-methyl-2-propanol, potassium salt (0.144 mol) was added portionwise. The mixture was stirred at a low temperature for 30 min, at room temperature for 30 min, hydrolyzed and acidified with HCl. The precipitate was filtered off, rinced and dried, yielding 17 g (51.8%) of 5-(3-chlorophenyl)-7-[2-(4-chlorophenyl)-1,3-dioxolan-2-yl]-1,5-dihydro-4,1-benzoxazepin-2(3H)-one (intermediate 11), mp. 205° C.
後処理
- temperaturewas cooled on an ice bath
- filtrationThe precipitate was filtered off
- customdried
出典と根拠
- ORDレコード
- ord-f267ef298553477e8863df6584e8295c
- 出典データセット
- uspto-grants-2006_12
- 特許番号
- US07153958B2
関連ノート
読み込み中…